These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 37568284)

  • 1. PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer.
    McGale J; Khurana S; Huang A; Roa T; Yeh R; Shirini D; Doshi P; Nakhla A; Bebawy M; Khalil D; Lotfalla A; Higgins H; Gulati A; Girard A; Bidard FC; Champion L; Duong P; Dercle L; Seban RD
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular imaging of HER2 expression in breast cancer patients using a novel peptide-based tracer
    Shi J; Du S; Wang R; Gao H; Luo Q; Hou G; Zhou Y; Zhu Z; Wang F
    J Transl Med; 2023 Jan; 21(1):19. PubMed ID: 36631812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.
    Mortimer JE; Bading JR; Colcher DM; Conti PS; Frankel PH; Carroll MI; Tong S; Poku E; Miles JK; Shively JE; Raubitschek AA
    J Nucl Med; 2014 Jan; 55(1):23-9. PubMed ID: 24337604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT.
    Ulaner GA; Hyman DM; Ross DS; Corben A; Chandarlapaty S; Goldfarb S; McArthur H; Erinjeri JP; Solomon SB; Kolb H; Lyashchenko SK; Lewis JS; Carrasquillo JA
    J Nucl Med; 2016 Oct; 57(10):1523-1528. PubMed ID: 27151988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe
    Li L; Wu Y; Wang Z; Jia B; Hu Z; Dong C; Wang F
    J Nucl Med; 2017 May; 58(5):821-826. PubMed ID: 28104744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
    Ulaner GA; Hyman DM; Lyashchenko SK; Lewis JS; Carrasquillo JA
    Clin Nucl Med; 2017 Dec; 42(12):912-917. PubMed ID: 28872549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Epidermal Growth Factor Receptor 2-Targeted PET/Single- Photon Emission Computed Tomography Imaging of Breast Cancer: Noninvasive Measurement of a Biomarker Integral to Tumor Treatment and Prognosis.
    Henry KE; Ulaner GA; Lewis JS
    PET Clin; 2017 Jul; 12(3):269-288. PubMed ID: 28576166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic Response Monitoring with
    Kang M; Shin JI; Han S; Kim JY; Park J; Kim KI; Kang JH; Lee TS
    Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.
    Gebhart G; Lamberts LE; Wimana Z; Garcia C; Emonts P; Ameye L; Stroobants S; Huizing M; Aftimos P; Tol J; Oyen WJ; Vugts DJ; Hoekstra OS; Schröder CP; Menke-van der Houven van Oordt CW; Guiot T; Brouwers AH; Awada A; de Vries EG; Flamen P
    Ann Oncol; 2016 Apr; 27(4):619-24. PubMed ID: 26598545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular probes targeting HER2 PET/CT and their application in advanced breast cancer.
    Gao F; Liu F; Wang J; Bi J; Zhai L; Li D
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):118. PubMed ID: 38466436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted
    Ulaner GA; Carrasquillo JA; Riedl CC; Yeh R; Hatzoglou V; Ross DS; Jhaveri K; Chandarlapaty S; Hyman DM; Zeglis BM; Lyashchenko SK; Lewis JS
    Radiology; 2020 Aug; 296(2):370-378. PubMed ID: 32515679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
    McLarty K; Cornelissen B; Cai Z; Scollard DA; Costantini DL; Done SJ; Reilly RM
    J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and preclinical studies of
    Lam K; Chan C; Reilly RM
    MAbs; 2017 Jan; 9(1):154-164. PubMed ID: 27813707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of HER2 targeted 64 Cu-DOTA-tagged PET imaging in gastric cancer patients.
    Hernandez MC; Yazaki P; Mortimer JE; Yamauchi D; Poku E; Park J; Frankel P; Kim J; Colcher DM; Wong J; Fong Y; Shively J; Woo Y
    Nucl Med Commun; 2023 Dec; 44(12):1151-1155. PubMed ID: 37901917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
    Cheng J; Wang Y; Mo M; Bao X; Zhang Y; Liu G; Zhang J; Geng D
    Oncotarget; 2015 Oct; 6(30):29388-95. PubMed ID: 26336821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Lu Y; Li M; Massicano AVF; Song PN; Mansur A; Heinzman KA; Larimer BM; Lapi SE; Sorace AG
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33809310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide Based Imaging Agents for HER2 Imaging in Oncology.
    Ducharme M; Lapi SE
    Mol Imaging; 2020; 19():1536012120960258. PubMed ID: 32957830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.
    Sandberg D; Tolmachev V; Velikyan I; Olofsson H; Wennborg A; Feldwisch J; Carlsson J; Lindman H; Sörensen J
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1337-1346. PubMed ID: 28261749
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.